Literature DB >> 16333191

Ocular manifestations of leptospirosis.

S R Rathinam1.   

Abstract

Leptospiral uveitis is a common entity in tropical countries. Ocular manifestations are noted in the second phase of illness, but these remain under-diagnosed mainly because of the prolonged symptom-free period that separates the systemic manifestations from detection of ocular manifestations. Varying ophthalmic presentations and the intrinsic nature of different types of uveitis to mimic one another also challenge the accuracy of the diagnosis. Of the individual ocular signs, the combination of acute, non-granulomatous, panuveitis, hypopyon, vasculitis, optic disc edema, membranous vitreous opacities and absence of choroiditis or retinitis have high predictive value for the clinical diagnosis of leptospiral uveitis. Geographic location of the patient, occupation, socio-economic status, risk factors related to exposure, past history of fever or jaundice also aid in diagnosis. Steroids are the mainstay of treatment for leptospiral uveitis. Depending upon the severity and anatomical location of inflammatory lesion, topical, peri-ocular and/or systemic steroids are given. The prognosis is generally good, even when the inflammation is severe.

Entities:  

Mesh:

Year:  2005        PMID: 16333191

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  18 in total

1.  LruA and LruB antibodies in sera of humans with leptospiral uveitis.

Authors:  Ashutosh Verma; S R Rathinam; C Gowri Priya; V R Muthukkaruppan; Brian Stevenson; John F Timoney
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

2.  Granulomatosis with polyangiitis: seeing the diagnosis.

Authors:  Max J Blumberg; Cynthia I Tung; Lindsay A May; Sangita P Patel
Journal:  BMJ Case Rep       Date:  2017-05-09

Review 3.  Leptospirosis in humans.

Authors:  David A Haake; Paul N Levett
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 4.  Antimicrobial guide to posterior segment infections.

Authors:  Tapan P Patel; David N Zacks; Vaidehi S Dedania
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-06       Impact factor: 3.117

5.  Spirochetal uveitis: Spectrum of clinical manifestations, diagnostic and therapeutic approach, final outcome and epidemiological data.

Authors:  Dimitrios Kalogeropoulos; Ioannis Asproudis; Maria Stefaniotou; Marilita Moschos; Constantina Gartzonika; Ioannis Bassukas; Spiros Konitsiotis; Haralampos Milionis; Georgios Gaitanis; Konstantinos Malamos; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-07-23       Impact factor: 2.031

6.  Infectious Uveitis.

Authors:  Phoebe Lin
Journal:  Curr Ophthalmol Rep       Date:  2015-06-13

7.  Actionable diagnosis of neuroleptospirosis by next-generation sequencing.

Authors:  Michael R Wilson; Samia N Naccache; Erik Samayoa; Mark Biagtan; Hiba Bashir; Guixia Yu; Shahriar M Salamat; Sneha Somasekar; Scot Federman; Steve Miller; Robert Sokolic; Elizabeth Garabedian; Fabio Candotti; Rebecca H Buckley; Kurt D Reed; Teresa L Meyer; Christine M Seroogy; Renee Galloway; Sheryl L Henderson; James E Gern; Joseph L DeRisi; Charles Y Chiu
Journal:  N Engl J Med       Date:  2014-06-04       Impact factor: 91.245

8.  Pica (Allotriophagy): An Underestimated Risk Factor for Severe Leptospirosis (Weil's Diseases)? Report of a Leptospira Septic Shock Successfully Managed with ECMO.

Authors:  Adam Fabiani; Eugenia Dal Bo; Stefano Di Bella; Marco Gabrielli; Alessandro Bologna; Umberto Albert; Gianfranco Sanson
Journal:  Infect Dis Rep       Date:  2021-07-05

9.  Commentary.

Authors:  Embong Zunaina
Journal:  J Neurosci Rural Pract       Date:  2012-05

10.  Leptospirosis presenting as neuroretinitis.

Authors:  Lakshya J Basumatary; Subhra Das; Marami Das; Munindra Goswami; Ashok K Kayal
Journal:  J Neurosci Rural Pract       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.